Skip to content
  • Saturday, 12 September 2026
  • 6:31 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Insilico CEO Sees Potentially $2.75 Billion Collaboration as ‘Fusing Lilly’s Clinical Excellence’ with Insilico’s ‘End-to-End AI Engine’
Laboratory Automation & Robotics

Insilico CEO Sees Potentially $2.75 Billion Collaboration as ‘Fusing Lilly’s Clinical Excellence’ with Insilico’s ‘End-to-End AI Engine’

Lana Keisha Apr 13, 2026 0

On March 29, Insilico Medicine, a pioneer in artificial intelligence-driven drug discovery, announced a landmark collaboration with pharmaceutical giant Eli…

Read More
Biotech & Genetic Research

Biotech Sector Thrives on Collaboration and Innovation, Charting Course for Future Discoveries at Major 2026 Scientific Gatherings

Jia Lissa Apr 9, 2026 0

The past two weeks have underscored a vibrant and increasingly collaborative biotech landscape, characterized by strategic partnerships aimed at addressing…

Read More
Advanced Materials Science

Indiana University Researchers Unveil Breakthrough in Cosmic Matter Mystery Through Global Neutrino Collaboration

Nila Kartika Wati Mar 23, 2026 0

In a landmark achievement for the field of particle physics, researchers at Indiana University (IU) have contributed to a significant…

Read More
Data Science & Bioinformatics

Abacus AI Unveils Integrated Platform Revolutionizing Software Development Through AI-Powered Agent Collaboration and ‘Vibe Coding’

Evan Lee Salim Mar 19, 2026 0

In a significant advancement for the software development landscape, Abacus AI has introduced an integrated platform designed to streamline and…

Read More

Posts pagination

1 2
Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trialRevolutionizing Document Management: Five Python Scripts Automate Tedious PDF Tasks for Enhanced Efficiency and SecurityRecordati Weighs CVC’s €10.9 Billion Acquisition Offer, Potentially Delisting from Italian Stock ExchangeTWiV 1292: Clinical update with Dr. Daniel Griffin
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy PorustobartScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ